The effect of exercise and vitamin D in postmenopausal women with metabolic syndrome

Phase 1

Conditions: Metabolic syndrome disease.
Metabolic syndrome
E88.81

Registration Number: IRCT20200122046217N1

Lead Sponsor: Islamic Azad University

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 48

Inclusion Criteria

confirmation of metabolic syndrome based on ATPIII criteria
Not having a specific diet and regular exercise program in the past year
25-OHD serum levels between 10 and 20 ng/ml
Being in menopause age

Exclusion Criteria

Presence of other cardiovascular disease
Surgical treatment of obesity
Presence of any other chronic disease or skeletal disorders
severe weight loss

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vitamin D levels. Timepoint: Prior to the beginning and at the end of the study. Method of measurement: By blood sampling.;Anthropometric indices. Timepoint: Before the study starts and after the study ends. Method of measurement: Using INBODY test.;Lipid profile. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Vaspin. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Apelin. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Interleukin-6. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Interleukin beta-1. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;C- reactive protein. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.;Tumor necrosis factor alpha. Timepoint: Before the study starts and after it ended. Method of measurement: Blood sampling.

Secondary Outcome Measures